Jun 10, 2021 8:30 am EDT Skye Bioscience Expands Clinical Advisory Board with the Appointment of Ophthalmology Expert Dr. Miguel González-Andrades
May 17, 2021 8:42 am EDT Skye Bioscience’s THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as Combination and Single Agent, in Preclinical Study
Mar 16, 2021 8:30 am EDT Skye Bioscience’s Cannabinoid-Derived Drug Candidate, THCVHS, Demonstrates No Eye Irritation in Preclinical Assessment
Mar 8, 2021 8:39 am EST Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to Scientific Advisory Board
Mar 3, 2021 8:37 am EST Skye Bioscience to Present at H.C. Wainwright Global Life Sciences Conference
Jan 19, 2021 8:30 am EST Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience